What is the current stock price of AbCellera Biologics, Inc.?

As of the latest update, AbCellera Biologics, Inc.'s stock is trading at $5.21 per share.

What's happening with AbCellera Biologics, Inc. stock today?

Today, AbCellera Biologics, Inc. stock is down by 1.05%, possibly due to recent market activity.

What is the market sentiment around AbCellera Biologics, Inc. stock?

Current sentiment around AbCellera Biologics, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is AbCellera Biologics, Inc.'s stock price growing?

Over the past month, AbCellera Biologics, Inc.'s stock price has increased by 18.30%.

How can I buy AbCellera Biologics, Inc. stock?

You can buy AbCellera Biologics, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol ABCL.

Who are the major shareholders of AbCellera Biologics, Inc. stock?

Major shareholders of AbCellera Biologics, Inc. include institutions such as Baker Bros. Advisors LP, The Capital Group Cos., Inc., Baillie Gifford & Co., according to the latest filings.

ABCL

AbCellera Biologics, Inc.

$5.21

1.05%

Trade Ideas Performance

Latest Closed Trade Idea

$5.21

1.05%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of AbCellera Biologics, Inc. (ABCL)

In the past six months, AbCellera reported its Q3 2025 financial results and appointed Dr. Stephen Quake to its Board of Directors. The company announced a settlement and patent license agreement with Bruker Corporation, which significantly contributed to its Q4 2025 revenue. The first patients were dosed in the Phase 2 portion of its Phase 1/2 clinical trial for ABCL635. AbCellera reported its full-year 2025 business results, beating EPS estimates for Q4 2025, but remained unprofitable. Several firms initiated or reiterated coverage, with positive ratings and target prices. Baker Bros. Advisors increased its stake in AbCellera to 10.8% of outstanding shares. ABCL shares increased by 53.2% since the beginning of the year, with an 18% gain in the week leading up to May 9, 2026. However, individual investors experienced a 10% stock drop in February 2026. AbCellera is scheduled to report its Q1 2026 financial results on May 11, 2026.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community